Fresenius Kabi AG - Strategic SWOT Analysis Review

Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. Its product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. The companys therapeutic expertise covers areas of blood volume substitution, fluid management, anesthesia, critical illness, liver insufficiency, renal insufficiency, maldigestion or malabsorption, diabetes mellitus and pediatrics. Its products and services are indicated for the treatment of critically and chronically ill patients.

Fresenius Kabi AG Key Recent Developments

Apr 08,2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion
Mar 01,2019: Akorn comments on favorable court order
Dec 10,2018: Fresenius Kabi announces U.S. availability of Omegaven (fish oil triglycerides) Injectable Emulsion
Dec 03,2018: Fresenius Kabi receives FDA drug shortage assistance award
Nov 29,2018: Fresenius Kabi is among the most reputable companies in Germany

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Fresenius Kabi AG - Key Facts
Fresenius Kabi AG - Key Employees
Fresenius Kabi AG - Key Employee Biographies
Fresenius Kabi AG - Key Operational Employees
Fresenius Kabi AG - Major Products and Services
Fresenius Kabi AG - History
Fresenius Kabi AG - Company Statement
Fresenius Kabi AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Fresenius Kabi AG - Business Description
Business Segment: Clinical Nutrition Products
Overview
Performance
Business Segment: Infusion Therapy Products
Overview
Performance
Business Segment: IV Drugs
Overview
Performance
Key Stats
Business Segment: Medical Devices and Transfusion Technology
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America/Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Kabi AG - Corporate Strategy
Fresenius Kabi AG - SWOT Analysis
SWOT Analysis - Overview
Fresenius Kabi AG - Strengths
Fresenius Kabi AG - Weaknesses
Fresenius Kabi AG - Opportunities
Fresenius Kabi AG - Threats
Fresenius Kabi AG - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Fresenius Kabi AG, Recent Deals Summary
Section 4 Companys Recent Developments
Apr 08, 2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion
Mar 01, 2019: Akorn comments on favorable court order
Dec 10, 2018: Fresenius Kabi announces U.S. availability of Omegaven (fish oil triglycerides) Injectable Emulsion
Dec 03, 2018: Fresenius Kabi receives FDA drug shortage assistance award
Nov 29, 2018: Fresenius Kabi is among the most reputable companies in Germany
Nov 27, 2018: Winner of Fresenius Kabis Clinical Nutrition research grant Latin America to begin study on omega-3 fatty acids
Nov 20, 2018: Fresenius Kabi issues voluntary nationwide recall of sodium chloride injection, USP, 0.9% due to product labeling incorrectly stating stoppers do not contain latex
Oct 30, 2018: Fresenius in Q3/18 with continued strong Group earnings growth in constant currency
Oct 12, 2018: Fresenius Kabi opens compounding center in Canada
Oct 11, 2018: Fresenius Kabi Opens New Pharmaceutical Compounding Centre in Mississauga, Ontario
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Fresenius Kabi AG, Key Facts
Fresenius Kabi AG, Key Employees
Fresenius Kabi AG, Key Employee Biographies
Fresenius Kabi AG, Key Operational Employees
Fresenius Kabi AG, Major Products and Services
Fresenius Kabi AG, History
Fresenius Kabi AG, Other Locations
Fresenius Kabi AG, Subsidiaries
Fresenius Kabi AG, Joint Venture
Fresenius Kabi AG, Key Competitors
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Fresenius Kabi AG, Recent Deals Summary

List Of Figures


Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals by Type, 2013 to YTD 2019

Enteral Feeding Tube Global Market Review and Outlook by 10 Companies (Fresenius Kabi, Halyard Health, Avanos Medical etc.), by Type (Closed Tip, Open Tip)

Enteral Feeding Tube report is in-depth investigation for Global market. Enteral Feeding Tube market was valued at USD XX million Global in 2018 and is forecasted to reach USD XXX

USD 3000 View Report

Enteral Feeding Tube Global Market Review and Outlook by 10 Companies (Fresenius Kabi, Halyard Health, Avanos Medical etc.), by Type (Closed Tip, Open Tip)

Enteral Feeding Tube report is in-depth investigation for Global market. Enteral Feeding Tube market was valued at USD XX million Global in 2018 and is forecasted to reach USD XXX

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available